We are live on ! Find out more
UOC

UBS O'Connor Portfolio holdings

AUM $3.38B
1-Year Est. Return 63.08%
This Fund
S&P 500
This Quarter Est. Return
+5.99%
1 Year Est. Return
+63.08%
3 Year Est. Return
+180.99%
5 Year Est. Return
+483.22%
10 Year Est. Return
+2,128.62%
AUM
$5.75B
AUM Growth
-$39.4M
Cap. Flow
-$636M
Cap. Flow %
-11.06%
Top 10 Hldgs %
22.09%
Holding
798
New
336
Increased
102
Reduced
128
Closed
170

Top Buys

Rank Stock Value
1
CFN
CAREFUSION CORPORATION
CFN
+$125M
2
CVD
COVANCE INC.
CVD
+$75.9M
3
AGN
Allergan Inc
AGN
+$71.6M
4
SIAL
SIGMA - ALDRICH CORP
SIAL
+$69.7M
5
PEP icon
PepsiCo
PEP
+$52.7M

Top Sells

Rank Stock Value
1
BABA icon
Alibaba
BABA
+$72.3M
2
VYX icon
NCR Voyix
VYX
+$64.1M
3
HUM icon
Humana
HUM
+$64M
4
CNQR
CONCUR TECHNOLOGIES INC
CNQR
+$63.4M
5
TSM icon
TSMC
TSM
+$62.3M

Sector Composition

Rank Sector Weight
1 Healthcare 11.85%
2 Consumer Discretionary 11.63%
3 Consumer Staples 10.69%
4 Industrials 10.3%
5 Technology 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ORBC
301
DELISTED
ORBCOMM, Inc.
ORBC
$1.14M 0.02%
+175,000
New +$1.1M
PBR.A icon
302
Petrobras Class A
PBR.A
$106B
$1.14M 0.02%
+150,000
New +$1.69M
XENT
303
DELISTED
Intersect ENT, Inc
XENT
$1.13M 0.02%
+60,759
New +$1.09M
TXMD icon
304
TherapeuticsMD
TXMD
$24.2M
$1.11M 0.02%
5,000
+500
+11% +$103K
WLL
305
DELISTED
Whiting Petroleum Corporation
WLL
$1.11M 0.02%
112
-110
-50% -$1.68M
RARE icon
306
Ultragenyx Pharmaceutical
RARE
$2.55B
$1.1M 0.02%
+25,000
New +$1.15M
MJN
307
DELISTED
Mead Johnson Nutrition Company
MJN
$1.09M 0.02%
10,801
-47,622
-82% -$4.75M
KITE
308
DELISTED
Kite Pharma, Inc.
KITE
$1.06M 0.02%
+18,445
New +$777K
EVFM
309
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$1.04M 0.02%
+1,551
New +$1.17M
BLCM
310
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$1.04M 0.02%
+4,524
New +$970K
CHD icon
311
Church & Dwight Co
CHD
$24.5B
$946K 0.02%
24,000
-69,600
-74% -$2.57M
GCVRZ
312
DELISTED
Sanofi Contingent Value Rights
GCVRZ
$944K 0.02%
1,203,178
– –
CLX icon
313
Clorox
CLX
$12.8B
$938K 0.02%
+9,000
New +$900K
SPLK
314
DELISTED
Splunk Inc
SPLK
$884K 0.02%
+15,000
New +$921K
HUBG icon
315
HUB Group
HUBG
$2.83B
$882K 0.02%
46,302
-825,462
-95% -$15.3M
EDR
316
DELISTED
Education Realty Trust Inc
EDR
$880K 0.02%
24,054
-11,304
-32% -$387K
ED icon
317
Consolidated Edison
ED
$40.2B
$871K 0.02%
13,199
+7,432
+129% +$466K
TV icon
318
Televisa
TV
$1.5B
$852K 0.01%
25,000
-6,200
-20% -$215K
CCEP icon
319
CALL
Coca-Cola Europacific Partners
CCEP
$47.9B
$835K 0.01%
402,200
+202,200
+101% +$8.72M
EIDO icon
320
iShares MSCI Indonesia ETF
EIDO
$489M
$823K 0.01%
+30,000
New +$810K
GEO icon
321
The GEO Group
GEO
$4.03B
$797K 0.01%
29,607
+20,098
+211% +$524K
INGR icon
322
Ingredion
INGR
$6.49B
$781K 0.01%
+9,201
New +$732K
BG icon
323
Bunge Global
BG
$20.9B
$770K 0.01%
+8,475
New +$746K
FTNT icon
324
Fortinet
FTNT
$117B
$766K 0.01%
+125,000
New +$674K
SPG icon
325
Simon Property Group
SPG
$71.9B
$763K 0.01%
4,191
-2,737
-40% -$486K
11 12
13
14 15

Similar funds

FNBT
FineMark National Bank & Trust Fort Myers, Florida $3.2B AUM 18.28% 1-Year Est. Return
SAG
SageView Advisory Group Newport Beach, California $2.96B AUM 15.81% 1-Year Est. Return
ACI
Alpha Cubed Investments Irvine, California $2.92B AUM 31.27% 1-Year Est. Return
TCOV
Trust Company of Vermont Brattleboro, Vermont $2.4B AUM 18.8% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
A
AlphaQuest New York $1.79B AUM 10.61% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
CB
Cadence Bank Tupelo, Mississippi $1.71B AUM 16.17% 1-Year Est. Return

UBS O'Connor's Q4 2014 Portfolio in Review

As of Q4 2014, UBS O'Connor held 798 positions worth $5.75B, down 0.68% from $5.79B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

UBS O'Connor withdrew a net $636M in Q4 2014, closing 170 positions and reducing 128 holdings. Its most notable exit was NCR Voyix, an estimated $64.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 8.1% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, UBS O'Connor opened a new position in CAREFUSION CORPORATION worth $129M.

  • UBS O'Connor's largest Q4 2014 buy was CAREFUSION CORPORATION: 2,168,433 shares worth $129M.
  • UBS O'Connor added most to Allergan Inc in Q4 2014, an estimated $71.6M increase.
  • UBS O'Connor's biggest Q4 2014 reduction was Alibaba, cutting an estimated $72.3M.
  • UBS O'Connor fully exited NCR Voyix in Q4 2014, selling an estimated $64.1M.
  • UBS O'Connor's ten largest holdings make up 22% of its $5.75B portfolio in Q4 2014.
  • UBS O'Connor opened 336 new positions and closed 170 in Q4 2014.
  • UBS O'Connor's portfolio value fell 0.68% quarter-over-quarter to $5.75B.

Based on UBS O'Connor's 13F filing for Q4 2014, filed 13 Feb 2015.